Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape

Area of Science:

• Immunology
• Cell Biology
• Epigenetics

Background:

• Foxp3+CD4+ regulatory T (Treg) cells are crucial for immune homeostasis and preventing autoimmunity.
• Treg cell lineage commitment occurs during thymic selection, preceding Foxp3 expression, but the role of non-TCR signals remains unclear.

Purpose of the Study:

• To investigate the role of Interleukin-2 (IL-2) signaling in establishing the epigenetic and functional identity of thymic-derived Treg cells.
• To determine the impact of reduced IL-2 signaling on Treg cell function and their ability to suppress autoreactive T cell responses.

Main Methods:

• Utilized a mouse model with experimentally reduced IL-2 signaling.
• Analyzed the positioning of the pioneer factor SATB1 in CD4+ thymocytes.
• Assessed genome-wide chromatin accessibility in thymic-derived Treg cells.
• Evaluated the suppressive capacity of Treg cells with varying IL-2 signaling levels in vitro and in vivo.

Main Results:

• IL-2 signaling regulates SATB1 positioning in CD4+ thymocytes.
• IL-2 controls genome-wide chromatin accessibility in thymic-derived Treg cells.
• Treg cells with low IL-2 signals exhibit impaired suppression of autoreactive T cell responses both in vitro and in vivo.

Conclusions:

• IL-2 signaling is critical for Treg cell epigenetic programming and functional maturation.
• Defective IL-2 signaling compromises Treg cell-mediated immune regulation, potentially contributing to autoimmunity.
• Findings suggest therapeutic potential for modulating IL-2 signaling to reprogram Treg cells for treating autoimmune diseases.